Given the impact and apparent specificity of PARPinh and Trabectedin with regard to the DNA damage/DDR system and EWSR1-FLI1 activity in ES, we decided to explore the effects of the combination through a series of in vitro and in vivo studies. Here, FLI1 is linked to Ewing sarcoma.